Condition: Kidney Transplant Rejection · Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Identification of a bacterial signature in the blood or stool that may be associated with acute rejection in patients treated with Nulojix during their first year of transplant.
This description comes directly from the study's public registry record.
Antoine Durrbach, MD-PhD · +33614112981 · antoine.durrbach@inserm.fr
florence Herr, PhD · +33663680985 · florence.herr@inserm.fr
Always discuss trial participation with your own doctor first.
| Nephrologie transplantation CHRU Besançon | Besançon, France | Recruiting |
| Néphrologie, hémodialyse, aphérèses, transplantation rénale | La Tronche, France | Recruiting |
| Nephrologie transplantation CHRU Nantes | Nantes, France | Recruiting |
| Nephrologie transplantation CHU Saint Louis Paris | Paris, France | Recruiting |
| Nephrologie transplantation CHU Pitié Salpetriere Paris | Paris, France | Recruiting |
| Nephrologie hôpital Henri-Mondor | Paris, France | Recruiting |
| Nephrologie transplantation CHRU Poitiers | Poitiers, France | Recruiting |
| Nephrologie transplantation CHRU Toulouse | Toulouse, France | Recruiting |
| Nephrologie transplantation CHRU Tours | Tours, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04736381